摘要
目的探讨糖化血红蛋白(HbA1c)与急性冠状动脉综合征(ACS)患者预后之间的关系。方法将ACS患者随机分为HbA1c正常组、HbA1c升高组,测定HbA1c浓度。结果HbA1c增高组的患者随访心功能NYHA分级、左室舒张末内径(LVDd)均明显高于HbA1c正常组(P均<0.05)。HbA1c增高组的左室射血分数(EF)明显低于HbA1c正常组(P<0.05)。结论HbA1c与ACS患者预后具有相关性,积极控制HbA1c可明显改善预后。
Objective To investigate the relation between HbAlc and prognosis of patients with ACS. Methods Patients with ACS were randomly divided into the normal HbAlc group and elevated HbAlc group. The levels of HbAlc were measured. Results NYHA grade and left ventrieular end--systolic diameter（LVDd） in elevated HbAlc patients were higher than those in the normal ones. Left ventricular ejection faction （EF） in the elevated patients was lower than that in the normal patients. Conclusion There is correlation between HbAlc and the prognosis of patients with ACS. We could significantly improve the prognosis of patients with ACS by the control of HbAlc level.
